国际肝胆健康（英文）Issue(1)：52-54,3.DOI:10.1016/j.iliver.2025.100148
Exploring emerging frontiers in hepatology:iLIVER's continuing journey
Exploring emerging frontiers in hepatology:iLIVER's continuing journey
Ming-Da Wang 1Xin-Fei Xu 1Lei Cai 2Tian Yang1
作者信息
- 1. Department of Hepatobiliary Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University(Naval Medical University),Shanghai 200438,China
- 2. Institute of Hepatopancreatobiliary Surgery,Chongqing General Hospital,Chongqing University,Chongqing 401147,China
- 折叠
摘要
关键词
Hepatocellular carcinoma/Metabolic dysfunction-associated fatty liver disease/Liver transplantation/Hepatobiliary surgery/BiomarkersKey words
Hepatocellular carcinoma/Metabolic dysfunction-associated fatty liver disease/Liver transplantation/Hepatobiliary surgery/Biomarkers引用本文复制引用
Ming-Da Wang,Xin-Fei Xu,Lei Cai,Tian Yang..Exploring emerging frontiers in hepatology:iLIVER's continuing journey[J].国际肝胆健康（英文）,2025,(1):52-54,3.
